Skip to content
Search

Latest Stories

Holland & Barrett begins stocking OTC medicines to help ‘customers stay well’

The retailer is trialling a range of over-the-counter medicines and health products in 20 of its stores

UK's health and well-being chain, Holland & Barret (H&B) is trying to widen its customer appeal by stocking a range of branded medicines.


The retailer added a new list of medicines and healthcare products in 20 of its stores as part of a limited trial last month.

The new list includes branded products like cold and cough, painkillers, women's health, gastrointestinal, skin treatments and hayfever.

These exclusive stores now offer a curated selection of products, including E45's skin treatments, Olbas' decongestant oils, and Jungle Formula's insect repellent.

Holland & Barrett spokesperson told Pharmacy Businessthat they want to “enable their customers to take better control of their health and stay well.”

“At Holland & Barrett we’re known for offering a wide range of innovative products to help our customers stay well, however, they’ve told us that sometimes they would like more immediate relief too.

“That’s why we’re trialling a selected range of medicines and healthcare products in around 20 stores, which is a range extension to give our customers more options to take control of their health and wellness,” the spokesperson said.

Medicines and healthcare trial 211 H&B is trialling a range of over-the-counter medicines and health products in 20 of its stores. Credit: The Academy PR

The British multi-national chain traditionally sells specialist health and wellness products, including vitamins, supplements and more recently speciality diets.

However, ever since the owner LetterOne completed a deal to buy back its £700m debt, the retailer has been investing heavily to improve its stores and customer offers.

Michelle Riddalls, CEO of the Proprietary Association of Great Britain (PAGB), commented on strategies to improve the line of products in the stores.

She said: “Holland & Barrett’s decision to widen their portfolio to include over-the-counter medicines is positive news for consumers; this will help even more people to self-care and take ownership of their health and well-being.

“We’re also delighted to announce that Holland & Barrett will be joining PAGB as members.”

As part of its new strategy, H&B is also expanding its presence in areas of the market that relate to its core health and wellness offer.

However, it could threaten the OTC revenue streams of the community pharmacies.

Gareth Jones, NPA Director of Corporate Affairs, said: “The public comes to community pharmacies for a wide range of reasons including the opportunity to get advice and clinical services from a pharmacist, to collect prescription and pharmacy medicines, as well as to purchase OTC medicines.

“Millions of people go to community pharmacies every week and that won’t change significantly with one additional retailer offering OTC medicines.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less